AIM ImmunoTech Inc.
AIM
$2.22
-$0.16-6.64%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 42.36% | 51.13% | 40.20% | -15.18% | -44.98% |
| Total Depreciation and Amortization | 4.35% | -1.20% | 3.36% | -31.43% | -29.23% |
| Total Amortization of Deferred Charges | -20.74% | 300.00% | -- | -- | -- |
| Total Other Non-Cash Items | -22.45% | 148.83% | 387.42% | 156.11% | 102.73% |
| Change in Net Operating Assets | 34.33% | -95.80% | -95.85% | -55.06% | 98.50% |
| Cash from Operations | 52.88% | 44.50% | 29.99% | -17.71% | -37.79% |
| Capital Expenditure | -- | -- | -- | 91.67% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -98.69% | -99.70% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5,284.91% | 721.51% | 637.43% | 198.68% | 120.46% |
| Cash from Investing | 4,722.03% | 731.80% | 665.63% | -71.29% | -96.46% |
| Total Debt Issued | -83.82% | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -35.19% | 71.29% | 83.92% | 197.93% | 850.77% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -38.64% | -- | -- | -- | -- |
| Cash from Financing | -61.26% | 33.01% | 1,228.66% | 1,543.20% | 4,246.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.40% | 88.07% | 82.71% | 1.01% | -30.34% |